Search clinical trials for: Sirolimus-Eluting Bx Velocity Coronary Stent (CypherTM Sirolimus-Eluting Stent)

Total 324 results

Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cordis Corporation

Completed

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (BIFURCATION)

Coronary Artery Disease

Italy
Brighton and Sussex University Hospitals NHS Trust
Abbott Medical Devices

Completed

Xience or Vision Stent Management of Angina in the Elderly (XIMA)

Coronary Artery Disease

United Kingdom
Aarhus University Hospital Skejby
Medtronic Cardiovascular; Biosensors International

Completed

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® (SO VI)

Coronary Artery Disease | Angina Pectoris

Denmark
Odense University Hospital

Unknown

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent (SORT OUT VII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)

Coronary Artery Disease

Japan
Masaryk University

Unknown

Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction (ROBUST)

Coronary Heart Disease | Percutaneous Coronary Intervention

Czech Republic
Shigeru Saito
NPO International TRI Network

Terminated

Nobori And Uncoated Stent In Coronary Attack

Acute Myocardial Infarction

Japan
Odense University Hospital

Completed

Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation (OCTACS)

Myocardial Infarction | Coronary Artery Disease
Yonsei University

Unknown

Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents (CTO)

Coronary Artery Disease

Korea, Republic of
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
Cordis Corporation

Completed

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Coronary Stenosis
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Hyogo College of Medicine

Withdrawn

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (ASSESS)

Coronary Artery Disease | Atherosclerosis

Japan
Catholic University of the Sacred Heart

Completed

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (Z-SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Meril Life Sciences Pvt. Ltd.
Lifecare Institute of Medical Sciences and Research Ahmedabad Gujarat India

Completed

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions (meriT-1)

Coronary Artery Disease

India
Instituto Nacional de Cardiologia Ignacio Chavez

Recruiting

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk (ZEVS-HBR)

Coronary Artery Disease | Percutaneous Coronary Intervention | High Bleeding Risk

Mexico
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) (PROTECT)

Ischemic Heart Disease

Netherlands
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions (LONG-DES-V)

Coronary Artery Disease

Korea, Republic of
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions (ISAR-CABG)

Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Germany
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Catholic University of the Sacred Heart

Completed

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Seung-Jung Park
Medtronic; CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV) (LONG-DES-IV)

Coronary Artery Disease

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Cordis Corporation

Completed

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Coronary Artery Disease
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy
Medfavour (Beijing) Medical Co., Ltd
Chinese Academy of Medical Sciences, Fuwai Hospital; Division of Biometrics...

Unknown

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Coronary Artery Diseases

China
Deutsches Herzzentrum Muenchen

Unknown

Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography (PPS/PFS-OCT)

Coronary Heart Disease

Germany
Charite University, Berlin, Germany
Techniker Krankenkasse

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (GERSHWIN)

Coronary Artery Disease

Germany
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Supralimus-Core™ Pharmacokinetic (PK) Study

Coronary Artery Disease

India
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
OrbusNeich
CCRF Inc., Beijing, China; OrbusNeich Medical (Shenzhen), Co. Ltd.

Completed

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions (RECOVERY)

Coronary Arteriosclerosis

China
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Patients With Coronary Artery Disease (CAD) (RACES)

Coronary Artery Disease | Coronary Atherosclerosis

Italy
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
University of Freiburg

Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents (EVERBIOII)

Coronary Artery Disease

Switzerland
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Nanjing First Hospital, Nanjing Medical University

Withdrawn

Coronary Bifurcation Lesions Treated With Biguard Stent System (BIGUARD)

Coronary Artery Disease
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Coronary Artery Disease

Korea, Republic of
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States

Search clinical trials for: Sirolimus-Eluting Bx Velocity Coronary Stent (CypherTM Sirolimus-Eluting Stent)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations